The EIF2A Knockout HeLa Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of HeLa cells with targeted disruption of the EIF2A gene, establishing a loss-of-function model for non-canonical translation initiation studies. The heterogeneous polyclonal format captures diverse editing events without clonal selection, enabling investigation of gene function in a physiologically relevant mixed cell context.
HeLa cells, an HPV18-positive epithelial line derived from cervical adenocarcinoma, are widely utilized in cancer biology and translation research due to their well-characterized signaling pathways and rapid proliferation. This host model offers a pertinent background for examining the role of alternative translation mechanisms in oncogenic stress adaptation.
EIF2A mediates cap-independent translational initiation by delivering Met-tRNAi to the 40S ribosomal subunit when canonical eIF2 is inhibited, driving IRES-dependent synthesis of stress-responsive proteins. Upstream regulators such as PERK, GCN2, PKR, HRI, and mTORC1 link EIF2A activity to amino acid deprivation, ER stress, and viral infection. Downstream, it modulates levels of ATF4, CHOP, c-MYC, HIF1A, VEGF, and BCL2, thus influencing apoptosis, proliferation, and angiogenesis. EIF2A physically interacts with the 40S subunit, initiator tRNA, eIF5B, and eIF3, integrating signals from the integrated stress response and mTOR pathways.
In HeLa cervical adenocarcinoma cells, EIF2A disruption allows dissection of its contribution to stress survival and translational reprogramming, particularly under conditions that impair canonical eIF2 function. The polyclonal knockout population avoids single-cell clone artifacts and may better model heterogeneous tumor cell responses to therapy-induced stress, such as those encountered during drug resistance studies.
Applications include polysome profiling to assess global translation changes, dual-luciferase IRES reporter assays for quantifying cap-independent initiation, and immunofluorescence for stress granule analysis. Additional uses encompass flow cytometry-based apoptosis and viability assays, RNA-seq transcriptome analysis, and Western blotting of downstream targets like ATF4 and CHOP. This model supports research into cancer cell survival, viral IRES utilization, and translation dysregulation in neurodegeneration. For technical inquiries or custom knockout projects, please contact Ascent Research.
